NCT00752960View on ClinicalTrials.gov

DNA Diagnostics for Minimizing Metabolic Side-Effects of Antipsychotics

UnknownOBSERVATIONAL
Enrollment

1,000

Participants

Timeline

Start Date

January 31, 2007

Primary Completion Date

December 31, 2009

Study Completion Date

December 31, 2009

Conditions
Psychoses
Trial Locations (2)

40508

RECRUITING

University of Kentucky, Lexington

06106

RECRUITING

Hartford Hospital Institute of Living, Hartford

Sponsors

Lead Sponsor

Genomas, Inc
All Listed Sponsors
collaborator

Hartford Hospital

OTHER

collaborator

University of Kentucky

OTHER

lead

Genomas, Inc

INDUSTRY

NCT00752960 - DNA Diagnostics for Minimizing Metabolic Side-Effects of Antipsychotics | Biotech Hunter | Biotech Hunter